NL-OMON49307已完成4 期
MULTINATIONAL, MULTICENTRE, PROSPECTIVE, LONG-TERM SAFETY AND EFFICACY FOLLOW-UP STUDY AFTER AUTOLOGOUS CULTIVATED LIMBAL STEM CELLS TRANSPLANTATION (ACLSCT) FOR RESTORATION OF CORNEAL EPITHELIUM IN PATIENTS WITH LIMBAL STEM CELL DEFICIENCY DUE TO OCULAR BURNS - HOLOCORE-F
Holostem Terapie Avenzate S.r.l0 个研究点目标入组 4 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 4
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •All adult patients who completed the HOLOCORE core study and who consent to
- •roll over to the present extension study at the end of the HOLOCORE follow-up.
排除标准
- •No specific exclusion criterion is considered for this study, except for
- •patients dropping out from the HOLOCORE study or withdrawing consent.
研究者
相似试验
进行中（未招募）
1 期
A clinical study to follow up the implantation of Holoclar on the cornea of patients with ocular burnscorneal lesions with associated moderate to severe limbal stem celldeficiency due to ocular burnsMedDRA version: 20.0Level: LLTClassification code 10011012Term: Corneal epithelium opacitySystem Organ Class: 100000004853EUCTR2015-001344-11-FRChiesi Farmaceutici S.p.A.75
进行中（未招募）
1 期
A clinical study to follow up the implantation of Holoclar on the cornea of patients with ocular burnsEUCTR2015-001344-11-NLChiesi Farmaceutici S.p.A.70
进行中（未招募）
1 期
A clinical study to follow up the implantation of Holoclar on the cornea of patients with ocular burnsEUCTR2015-001344-11-ITCHIESI FARMACEUTICI S.P.A.70
进行中（未招募）
1 期
A clinical study to follow up the implantation of Holoclar on the cornea of patients with ocular burnsCorneal lesions with associated moderate to severe limbal stem celldeficiency due to ocular burnsMedDRA version: 20.0Level: LLTClassification code 10011012Term: Corneal epithelium opacitySystem Organ Class: 100000004853EUCTR2015-001344-11-ESChiesi Farmaceutici S.p.A.70
进行中（未招募）
1 期
A clinical study to follow up the implantation of Holoclar on the cornea of patients with ocular burnsEUCTR2015-001344-11-DEHolostem Terapie Avanzate s.r.l.70